X-132072994-A-G
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_016542.4(STK26):āc.1127A>Gā(p.Gln376Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000422 in 1,209,364 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 21 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_016542.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
STK26 | NM_016542.4 | c.1127A>G | p.Gln376Arg | missense_variant | 11/12 | ENST00000394334.7 | NP_057626.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
STK26 | ENST00000394334.7 | c.1127A>G | p.Gln376Arg | missense_variant | 11/12 | 1 | NM_016542.4 | ENSP00000377867.2 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112534Hom.: 0 Cov.: 23 AF XY: 0.0000576 AC XY: 2AN XY: 34696
GnomAD3 exomes AF: 0.0000716 AC: 13AN: 181549Hom.: 0 AF XY: 0.0000449 AC XY: 3AN XY: 66829
GnomAD4 exome AF: 0.0000447 AC: 49AN: 1096830Hom.: 0 Cov.: 30 AF XY: 0.0000524 AC XY: 19AN XY: 362394
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112534Hom.: 0 Cov.: 23 AF XY: 0.0000576 AC XY: 2AN XY: 34696
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.1127A>G (p.Q376R) alteration is located in exon 11 (coding exon 10) of the STK26 gene. This alteration results from a A to G substitution at nucleotide position 1127, causing the glutamine (Q) at amino acid position 376 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2023 | STK26: BP4, BS2 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at